-
641
Molecular Mechanism of Stem Cell Differentiation into Adipocytes and Adipocyte Differentiation of Malignant Tumor
Published 2020-01-01“…Understanding the molecular mechanism of adipogenesis and adipose differentiation of cancer cells may contribute to cancer treatments that involve inducing differentiation into benign cells.…”
Get full text
Article -
642
Integrated Bioinformatics and Experimental Approaches Identified the Role of NPPA in the Proliferation and the Malignant Behavior of Breast Cancer
Published 2021-01-01“…And we observed the enhanced proliferation, migration, and invasion potential of breast cancer cells after NPPA depletion. Further, we predicted the transcription modulation of NPPA with PROMO and JASPAR. …”
Get full text
Article -
643
LINC00707 Regulates miR-382-5p/VEGFA Pathway to Enhance Cervical Cancer Progression
Published 2021-01-01“…In addition, the action of LINC00707 in cervical cancer cells was studied using bioinformatic tools and luciferase reporter experiment. …”
Get full text
Article -
644
Apigenin is an anoikis sensitizer with strong anti-metastatic properties in experimental breast cancer
Published 2024-07-01“…Blockage of TXA2 signaling up-regulated p53 as well as its target gene p21, caused a G1 phase arrest, and finally led to apoptosis in breast cancer cells. TXA2 level was positively correlated with breast cancer cell anoikis rate, and apigenin significantly inhibited TXA2 biosynthesis in vitro and in vivo. …”
Get full text
Article -
645
Pure Testicular Seminoma Relapsing Late with Somatic Type Malignancy
Published 2017-01-01“…Pathogenetic hypotheses involve direct transformation of teratoma, origin from totipotent cancer cells, or derivation from yolk sac tumour elements. …”
Get full text
Article -
646
The prognostic effect of immunohistochemical staining rates in patients with non–muscle-invasive bladder cancer
Published 2023-07-01“…Materials and Methods: Levels of OCT-4, CD47, p53, Kİ-67, and Survivin proteins in cancer cells were determined with a semi-quantitative immunohistochemical experiment. …”
Get full text
Article -
647
Response Gene to Complement 32 is associated with poor patient survival and an inflamed tumor-immune microenvironment in clear cell renal cell carcinoma
Published 2025-02-01“…In vitro studies showed that RGC-32 expression in renal cancer cells was downregulated by activated immune cells. …”
Get full text
Article -
648
Comprehensive Overview of Ketone Bodies in Cancer Metabolism: Mechanisms and Application
Published 2025-01-01“…The ketogenic diet (KD) may enhance the sensitivity of various cancers to standard therapies, such as chemotherapy and radiotherapy, by exploiting the reprogrammed metabolism of cancer cells and shifting the metabolic state from glucose reliance to KB utilization, rendering it a promising candidate for adjunct cancer therapy. …”
Get full text
Article -
649
The Use of Porous Scaffold as a Tumor Model
Published 2013-01-01“…It is therefore critical to mimic the cancer cells and their surrounding environment during in vitro study. …”
Get full text
Article -
650
Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis
Published 2025-02-01“…Abstract Sphingolipid, ceramide for example, plays an essential role in regulating cancer cell death. Defects in the generation and metabolism of ceramide in cancer cells contribute to tumor cell survival and resistance to chemotherapy. …”
Get full text
Article -
651
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
Published 2015-01-01“…Similarly, cancer cells are able to use these checkpoints to avoid immune control and rejection. …”
Get full text
Article -
652
Targeting the 8-oxodG Base Excision Repair Pathway for Cancer Therapy
Published 2025-01-01“…BER inhibitors have recently been identified as a promising approach in cancer therapy, increasing the sensitivity of cancer cells to radiotherapy and chemotherapy. By exploiting tumor-specific DNA repair dependencies and synthetic lethal interactions, these inhibitors could be used to selectively target cancer cells while sparing normal cells. …”
Get full text
Article -
653
Unraveling the Molecular Nexus between GPCRs, ERS, and EMT
Published 2021-01-01“…Uncontrolled proliferation and persistent metabolism of cancer cells also induce oxidative stress, hypoxia, and depletion of growth factors and nutrients. …”
Get full text
Article -
654
A Novel In Situ Dendritic Cell Vaccine Triggered by Rose Bengal Enhances Adaptive Antitumour Immunity
Published 2022-01-01“…Recent studies have shown that Rose Bengal (RB) can effectively induce immunogenic cell death (ICD) in cancer cells, presenting whole tumour antigens for DC processing and presentation. …”
Get full text
Article -
655
circ_0052184 Promotes Colorectal Cancer Progression via Targeting miR-604/HOXA9 Axis
Published 2022-01-01“…Expression of circ_0052184 was significantly increased in colorectal cancer cell lines and tissues. Silencing circ_0052184 affected the proliferation, migration, and invasion of colorectal cancer cells. miR-604 was targeted by circ_0052184. …”
Get full text
Article -
656
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
Published 2018-01-01“…Adoptive cell therapy functions by stimulating and cultivating autologous lymphocytes ex vivo and then reinfusing them into the patient to kill cancer cells. Cancer vaccination is performed using antigenic substances to activate tumor-specific immune responses. …”
Get full text
Article -
657
Exploring therapeutic strategies for androgen-independent prostate cancer using a magnetic coculture platform
Published 2025-06-01“…Employing this straightforward coculture method, we observed significant growth, motility, and cluster formation of prostate cancer cells upon direct contact with surrounding fibroblasts. …”
Get full text
Article -
658
Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer
Published 2025-01-01“…The quantity and cross‐linking status of ECM components are crucial factors in tumor development, as they determine tissue stiffness and the interaction between stiff TME and cancer cells, resulting in aberrant mechanotransduction, proliferation, migration, invasion, angiogenesis, immune evasion, and treatment resistance. …”
Get full text
Article -
659
Prospects for the use of <i>Bacillus anthracis</i> toxin in cancer therapy
Published 2022-12-01“…The paper presents data from the studies that characterize the structure and functions of the lethal factor, reflect the results of its application on cancer cells both as a part of anthrax toxin and as a separate unit, reveal its therapeutic potential. …”
Get full text
Article -
660
Extraction efficiency and bioactive evaluation of Tamarix nilotica and Arthrocnemum macrostachyum extracts for anti-cancer potential.
Published 2025-01-01“…Results suggest that: 1) MAE is more efficient than maceration in recovering metabolites from plant biomass based on measurements of total phenolic content, radical scavenging activity, and bioactivity of extracts based on in vitro cytotoxicity. 2) Only T. nilotica extracts were found to be bioactive based on cytotoxicity measurements. 3) Cancer cell lines displayed differential sensitivity to T. nilotica crude extracts, with breast cancer cells being the most sensitive and lung cancer cells being the least sensitive. 4) Solid-phase fractionation of T. nilotica crude extract using different percentages of methanol resulted in several fractions that were 100-fold more cytotoxic compared to the crude unfractionated extract. …”
Get full text
Article